First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

BACKGROUND: In metastatic renal-cell carcinoma (mRCC), recent data have shown efficacy of first-line ipilimumab and nivolumab (ipi-nivo) as well as immuno-oncology (IO)/vascular endothelial growth factor (VEGF) inhibitor combinations. Comparative data between these strategies are limited. OBJECTIVE:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Dudani, Shaan, Graham, Jeffrey, Wells, J. Connor, Bakouny, Ziad, Pal, Sumanta K., Dizman, Nazli, Donskov, Frede, Porta, Camillo, de Velasco, Guillermo, Hansen, Aaron, Iafolla, Marco, Beuselinck, Benoit, Vaishampayan, Ulka N., Wood, Lori A., Liow, Elizabeth, Yan, Flora, Yuasa, Takeshi, Bjarnason, Georg A., Choueiri, Toni K., Heng, Daniel Y.C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858928/
https://ncbi.nlm.nih.gov/pubmed/31445844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.07.048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados